Abstract Objective We have observed alterations of quantitative (q)-EEG findings occurring in interferon (IFN)-α treated chronic hepatitis C (CH-C) patients
Introduction

Alterations of brain waves on electroencephalograms (EEGs) during treatment with interferon (IFN)-α have been described previously in several case reports (1-3). We have confirmed a diffuse slowing based on an analysis of blind, prospective and serial quantitative-EEG (q-EEG) examina-
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tions undertaken in many patients with IFN-α treated chronic hepatitis C (4). We speculated that such diffuse slowing on the EEGs could reflect a mild encephalopathy due to the IFN-α. We recently reported that the alteration of the q-EEG could be estimated clinically by the change in score on Mini-Mental State Examinations (5). We have also reported that the age of the patients was one of the factors affecting such alterations on the q-EEG (6). However, no other such factors have been reported. The present study was the first to evaluate the relationship between the alterations in q-EEG findings that occur during IFN-α treatment and the severity of hepatitis as estimated according to scales of staging and grading based on liver biopsies.
Methods
Patients
Q-EEG analysis
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) at the time of q-EEG examination after 2 weeks of IFN-α administration, and no patient with pyrexia at the time of examination at weeks. The two patients with mild pyrexia had findings of mild severity on liver biopsy. No significant effects of pyrexia on q-EEG were found.
Discussion
Although numerous patients have undergone IFN-α treatment, detailed assessments of the adverse effects of IFN-α on central nervous system function have not yet been presented. Evaluations of alterations in brain function have been presented in only three previous reports based on data from small numbers of patients who underwent EEG examinations (1-3). We recently confirmed a significant, diffuse slowing on q-EEGs that occurred in chronic hepatitis C patients during IFN-α treatment at a relatively low dosage (4). With such a low dosage of IFN-α administration to chronic hepatitis C patients, the diffuse slowing of the EEG is re-
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